Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 5028-5036

  Granoff, Dan M ^a,c   Bartoloni, Antonella ^b   Ricci, Stefano ^b   Gallo, Eugenia ^b   Rosa, Domenico ^b   Ravenscroft, Neil ^b   Guarnieri, Valentina ^b   Seid, Robert C ^b   Shan, Asra ^c   Usinger, William R ^c   Tan, Siqi ^c   McHugh, Yvonne E ^a   Moe, Gregory R ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b CHIRON VACCINES   (Italy)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; BACTERIUM ANTIBODY; COMPLEMENT; EPITOPE; MONOCLONAL ANTIBODY; POLYSIALIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BACTERIAL MEMBRANE; BACTERIOLYSIS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CROSS REACTION; EPITOPE MAPPING; FEMALE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MOLECULAR MIMICRY; MOUSE; NEISSERIA MENINGITIDIS; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL VACCINES; COMPLEMENT SYSTEM PROTEINS; CROSS REACTIONS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; FEMALE; HUMANS; MICE; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; SIALIC ACIDS;

EID: 15144360247     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jafari, H. S., B. A. Perkins, and J. D. Wenger. 1997. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid. Mortal. Wkly. Rep. 46:1.
2. Jones, D. 1995. Epidemiology of meningococcal disease in Europe and the USA. In Meningococcal Disease. K. Cartwright, ed. John Wiley & Sons, Chichester, U.K., p. 147.
3. Ramsay, M., E. Kaczmarski, M. Rush, R. Mallard, P. Farrington, and J. White. 1997. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun. Dis. Rep. CDR Rev. 7:R49.
4. Frasch, C. E. 1995. Meningococcal vaccines: past, present and future. In Meningococcal Disease. K. Cartwright, ed. John Wiley & Sons, Chichester, U.K., p. 245.
5. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. Cartwright. 1996. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J. Infect. Dis. 174:1360.
6. Lieberman, J. M., S. S. Chiu, V. K. Wong, S. Partridge, S. J. Chang, C. Y. Chiu, L. L. Gheesling, G. M. Carlone, and J. I. Ward. 1996. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children: a randomized controlled trial. J. Am. Med. Assoc. 275:1499.
7. Mandrell, R. E., F. H. Azmi, and D. M. Granoff. 1995. Complement-mediated bactericidal activity of human antibodies to poly α 2→8 N-acetyl neuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J. Infect. Dis. 172:1279.
8. Devi, S. J., W. D. Zollinger, P. J. Snoy, J. Y. Tai, P. Costantino, F. Norelli, R. Rappuoli, and C. E. Frasch, 1997. Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys. Infect. Immun. 65:1045.
9. Finne, J., U. Finne, H. Deagostini-Bazin, and C. Goridis. 1983. Occurrence of α 2→8 linked polysialosyl units in a neural cell adhesion molecule. Biochem. Biophys. Res. Commun. 112:482.
10. Finne, J., D. Bitter-Suermann, C. Goridis, and U. Finne. 1987. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138:4402.
11. Jennings, H. J., R. Roy, and A. Gamian. 1986. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J. Immunol. 137:1708.
12. Jennings, H. J., A. Gamian, and F. E. Ashton. 1987. N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis. J. Exp. Med. 165:1207.
13. Jennings, H. J. 1997. N-Propionylated group B meningococcal polysaccharide glycoconjugate vaccine against group B meningococcal meningitis. Int. J. Infect. Dis. 1:158.
14. Fusco, P. C., F. Michon, J. Y. Tai, and M. S. Blake. 1997. Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates. J. Infect. Dis. 175:364.
15. Häyrinen, J., H. Jennings, H. V. Raff, G. Rougon, N. Hanai, R. Gerardy-Schahn, and J. Finne. 1995. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1481.
16. Cremer, H., R. Lange, A. Christoph, M. Plomann, G. Vopper, J. Roes, R. Brown, S. Baldwin, P. Kraemer, S. Scheff, D. Barthels, K. Rajewsky, and W. Wille. 1994. Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature 367:455.
17. Rutishauser, U. 1992. NCAM and its polysialic acid moiety: a mechanism for pull/push regulation of cell interactions during development? Dev. Suppl. 99.
18. Westerink, M. A., P. C. Giardina, M. A. Apicella, and T. Kieber-Emmons. 1995. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92:4021.
19. 197 via adipic acid dihydrazide. Vaccine 13:463.
20. Jennings, H. J., R. Roy, and F. Michon. 1985. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis. J. Immunol. 134:2651.
21. Svennerholm, L. 1957. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24:604.
22. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265.
23. Azmi, F. H., A. H. Lucas, H. V. Raff, and D. M. Granoff. 1994. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect. Immun. 62:1776.
24. Livingston, B. D., J. L. Jacobs, M. C. Glick, and F. A. Troy. 1988. Extended polysialic acid chains (n greater than 55) in glycoproteins from human neuroblastoma cells. J. Biol. Chem. 263:9443.
25. Rougon, G., C. Dubois, N. Buckley, J. L. Magnani, and W. Zollinger. 1986. A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM. J. Cell Biol. 103:2429.
26. Stephens, D. S., J. S. Swartley, S. Kathariou, and S. A. Morse. 1991. Insertion of Tn916 in Neisseria meningitidis resulting in loss of group B capsular polysaccharide. Infect. Immun. 59:4097.
27. Pon, R. A., M. Lussier, Q. L. Yang, and H. J. Jennings. 1997. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J. Exp. Med. 185:1929.
28. Jennings, H. J., A. Gamian, F. Michon, and F. E. Ashton. 1989. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1. J. Immunol. 142:3585.
29. Agadjanyan, M., P. Luo, M. A. Westerink, L. A. Carey, W. Hutchins, Z. Steplewski, D. B. Weiner, and T. Kieber-Emmons. 1997. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nat. Biotechnol. 15:547.
30. Westerink, M. A., A. A. Campagnari, M. A. Wirth, and M. A. Apicella. 1988. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect. Immun. 56:1120.
31. Harris, S. L., L. Craig, J. S. Mehroke, M. Rashed, M. B. Zwick, K. Kenar, E. J. Toone, N. Greenspan, F. I. Auzanneau, J. R. Marino-Albernas, B. M. Pinto, and J. K. Scott. 1997. Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl. Acad. Sci. USA 94:2454.